Impact of IL28B SNPs on therapeutic outcome and liver histology differs between hepatitis C virus genotypes

Pharmacogenomics. 2012 Jun;13(8):847-9. doi: 10.2217/pgs.12.57.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Pharmacological
  • Genetic Association Studies
  • Hepacivirus / drug effects
  • Hepacivirus / genetics*
  • Hepatitis C* / drug therapy
  • Hepatitis C* / genetics
  • Hepatitis C* / virology
  • Hepatitis C, Chronic* / drug therapy
  • Hepatitis C, Chronic* / genetics
  • Hepatitis C, Chronic* / virology
  • Humans
  • Interferons / metabolism
  • Interleukins / genetics*
  • Liver / drug effects
  • Liver / pathology
  • Polymorphism, Single Nucleotide / genetics
  • Treatment Outcome

Substances

  • Biomarkers, Pharmacological
  • interferon-lambda, human
  • Interleukins
  • Interferons